[3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamen
- PMID: 20175227
- PMCID: PMC3583018
- DOI: 10.1002/syn.20748
[3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamen
Abstract
4-(Dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)benzamide (WC-10), a N-phenyl piperazine analog, displays high affinity and moderate selectivity for dopamine D(3) receptors versus dopamine D(2) receptors (Chu et al. [2005] Bioorg Med Chem 13:77-87). In this study, WC-10 was radiolabeled with tritium (specific activity = 80 Ci/mmol), and quantitative autoradiography studies were conducted using rhesus monkey and Sprague-Dawley rat brain sections. K(d) values for the binding of [3H]WC-10 to D(3) receptors obtained from quantitative autoradiography with rhesus monkey and rat brain sections are in agreement with K(d) values obtained from cloned human and rat receptors (Xu et al. [2009] Synapse 63:717-728). The D(2) selective antagonist [3H]raclopride binds with 11-fold higher affinity to human HEK D(2L) (K(d) = 1.6 nM) than HEK D(3) (K(d) = 18 nM) receptors; [3H]raclopride binds to rat Sf9 rD(2L) receptors with a K(d) of 6.79 nM, a value that is 4-fold lower than binding to human HEK D(2L) receptors and 2.5-fold higher than binding to rat Sf9 rD(3) receptors. In vitro quantitative autoradiography studies with [3H]WC-10 and [3H]raclopride were conducted on adult rat and rhesus monkey brain sections. A mathematical model for calculating the absolute densities of dopamine D(2) and D(3) receptors based on the in vitro receptor binding data of [3H]WC-10 and [3H]raclopride was developed.
Figures






Similar articles
-
[(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization.Synapse. 2009 Sep;63(9):717-28. doi: 10.1002/syn.20652. Synapse. 2009. PMID: 19425052 Free PMC article.
-
Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.Neurochem Int. 2001 Jan;38(1):31-42. doi: 10.1016/s0197-0186(00)00047-4. Neurochem Int. 2001. PMID: 10913686
-
(-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors.Eur J Pharmacol. 2001 Dec 7;432(2-3):143-7. doi: 10.1016/s0014-2999(01)01484-4. Eur J Pharmacol. 2001. PMID: 11740949
-
Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.Synapse. 2006 Dec 1;60(7):485-95. doi: 10.1002/syn.20325. Synapse. 2006. PMID: 16952157
-
N-(4-(4-(2-(2-[18F]Fluoroethoxy)phenyl)piperazine-1-yl)butyl)-4-(3-thienyl)benzamide.2011 Jun 24 [updated 2011 Oct 6]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2011 Jun 24 [updated 2011 Oct 6]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21994970 Free Books & Documents. Review.
Cited by
-
Regulation of dopamine presynaptic markers and receptors in the striatum of DJ-1 and Pink1 knockout rats.Neurosci Lett. 2013 Dec 17;557 Pt B(0 0):123-8. doi: 10.1016/j.neulet.2013.10.034. Epub 2013 Oct 22. Neurosci Lett. 2013. PMID: 24157858 Free PMC article.
-
The interactions of dopamine and oxidative damage in the striatum of patients with neurodegenerative diseases.J Neurochem. 2020 Jan;152(2):235-251. doi: 10.1111/jnc.14898. Epub 2019 Nov 4. J Neurochem. 2020. PMID: 31613384 Free PMC article.
-
Analysis of Human Dopamine D3 Receptor Quaternary Structure.J Biol Chem. 2015 Jun 12;290(24):15146-62. doi: 10.1074/jbc.M114.630681. Epub 2015 Apr 30. J Biol Chem. 2015. PMID: 25931118 Free PMC article.
-
Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface.J Biol Chem. 2012 Mar 16;287(12):8864-78. doi: 10.1074/jbc.M111.326678. Epub 2012 Jan 30. J Biol Chem. 2012. PMID: 22291025 Free PMC article.
-
Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?Ageing Res Rev. 2020 Jan;57:100994. doi: 10.1016/j.arr.2019.100994. Epub 2019 Nov 22. Ageing Res Rev. 2020. PMID: 31765822 Free PMC article. Review.
References
-
- Ariano MA, Sibley DR. Dopamine receptor distribution in the rat CNS: Elucidation using anti-peptide antisera directed against D1A and D3 subtypes. Brain Res. 1994;649:95–110. - PubMed
-
- Boundy VA, Luedtke RR, Gallitano AL, Smith JE, Filtz TM, Kallen RG, Molinoff PB. Expression and characterization of the rat D3 dopamine receptor: Pharmacologic properties and development of antibodies. J Pharmacol Exp Ther. 1993;264:1002–1011. - PubMed
-
- Camacho-Ochoa M, Walker EL, Evans DL, Piercey MF. Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist. Neurosci Lett. 1995;196:97–100. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous